Mortality in psoriatic arthritis patients, changes over time, and the impact of COVID-19: results from a multicenter Psoriatic Arthritis Registry (PsART-ID)
暂无分享，去创建一个
D. Solmaz | A. Erden | F. Yıldız | U. Kalyoncu | A. Omma | S. Aydın | K. Aksu | L. Kılıç | E. Dalkılıç | S. Akar | S. Yılmaz | O. Küçükşahin | G. Cetin | T. Kaşifoğlu | E. Tarhan | E. Gonullu | A. Tufan | M. Çınar | O. Bayindir | A. Doğru | V. Yazısız | G. Ayan | S. E. Esmen | C. Özişler | T. Duruoz | S. Pehlevan | S. Bakırcı | G. Kimyon | E. D. Ersozlu | S. Esmen | Esen Kasapoğlu Günal
[1] Philip Lewis,et al. COVID-19: Heterogeneous Excess Mortality and “Burden of Disease” in Germany and Italy and Their States and Regions, January–June 2020 , 2021, Frontiers in Public Health.
[2] C. Turesson,et al. Impact of the COVID-19 pandemic on morbidity and mortality in patients with inflammatory joint diseases and in the general population: a nationwide Swedish cohort study , 2021, Annals of the Rheumatic Diseases.
[3] D. Solmaz,et al. Patient characteristics and minimal disease activity in psoriatic arthritis: a transcontinental comparison , 2021, Clinical Rheumatology.
[4] S. Zhao,et al. Comorbidities in psoriatic arthritis: a systematic review and meta-analysis , 2021, Rheumatology International.
[5] J. Muellbauer,et al. Transatlantic excess mortality comparisons in the pandemic , 2020 .
[6] Md. Saiful Islam,et al. Effects of underlying morbidities on the occurrence of deaths in COVID-19 patients: A systematic review and meta-analysis , 2020, Journal of global health.
[7] D. Solmaz,et al. The Psoriatic Arthritis Registry of Turkey: results of a multicentre registry on 1081 patients , 2017, Rheumatology.
[8] C. Mok,et al. Life expectancy, standardized mortality ratios, and causes of death in six rheumatic diseases in Hong Kong, China. , 2011, Arthritis and rheumatism.
[9] B. Tom,et al. Improved survival in psoriatic arthritis with calendar time. , 2007, Arthritis and rheumatism.